We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization
News

Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization

Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization
News

Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Asuragen, Inc. has announced that it was selected to provide GLP compliant laboratory testing to assist in gene expression studies being conducted by Millennium Pharmaceuticals of Cambridge, MA.

Asuragen, a cGMP/GLP facility, is dedicated to helping the scientific community and industry to discover and develop new products for the advancement of cancer research and companion diagnostics.

“We are committed to applying our RNA expertise to produce the data quality required in clinical studies with organizations such as Millennium and believe that research like this may enable companion diagnostics and support the value of personalized medicine,” commented Scott Hunicke-Smith, V.P. and General Manager of Asuragen Services.

Advertisement